Japan 3D Printing Medical Devices Market Analysis Report 2022 to 30

Japan 3D Printing Medical Devices Market Analysis

$ 3999

Japan 3D Printing Medical Device Market is expected to witness growth from $185 Mn in 2022 to $639 Mn in 2030 with a CAGR of 16.80% for the forecasted year 2022-2030. The Japan market for 3D-printed medical devices is expanding as a result of the ongoing creation of new 3D printing technologies and materials. Production of intricate medical devices is becoming simpler and more affordable thanks to advancements in 3D printing technology. The market is segmented by application, by technology and by end user. Some key players in this market include: Materialise Japan, Roland dg, Siemens Healthineers, GE Healthcare, Stryker and Renishaw.

ID: IN10JPMD002 CATEGORY: Medical Devices GEOGRAPHY: Japan AUTHOR: Jigyasu Bhandari

Buy Now

Japan 3D Printing Medical Devices Market Executive Summary

The Japan 3D Printing Medical Devices Market size is at around $185 Mn in 2022 and is projected to reach $639 Mn in 2030, exhibiting a CAGR of 16.80% during the forecast period. The amount spent on healthcare per person in Japan has increased significantly from $4,256 in 2018, when it represented 10.75% of GDP, to $4,360 in 2019, when it would represent 10.74% of GDP. Given its high healthcare spending, the nation has a sophisticated and technologically advanced healthcare infrastructure. Japan had a death rate of 12.7 per 1,000 persons in 2022. In Japan, cancer accounts for 29% of fatalities.

One of the most developed 3D printing medical device markets is found in Japan. The nation has a strong healthcare system with a high usage of technology and a focus on cutting-edge medical devices like 3D imaging systems. Computed tomography scanners are the most widely used 3D imaging equipment in Japan out of all the different types of 3D imaging options, including X-ray imaging systems, CT, MRI, ultrasound, and nuclear imaging systems. The identification of diseases and ailments in the chest, abdomen, pelvis, and head, as well as the planning of radiation treatment, are just a few of the many uses for CT scans that are extensively used in Japan today.

Japan 3D Printing Medical Device Market

Market Dynamics

Market Growth Drivers

Around 28% of the population in Japan is over the age of 65, making it one of the countries with the highest percentage of elderly individuals worldwide. As a result of this demographic tendency, manufacturers now have a sizable market opportunity as demand for 3D Printing medical devices and implants rises. Recent advances in 3D printing technology have made it possible to produce complicated medical devices with extreme accuracy and precision. Manufacturers now have more opportunities to create cutting-edge products that specifically address the requirements of patients and healthcare professionals. Manufacturers may find the use of 3D printing technology to be cost-effective, particularly when producing high-end, low-volume medical equipment. Manufacturers can boost profitability and cut production expenses by utilising this technology.

Market Restraints

In Japan, 3D printed medical devices are subject to the same strict regulatory standards as other medical devices. Manufacturers must abide by rules established by various organisations, including the FDA, which can be time-consuming and expensive. Despite recent major advancements in 3D printing technology, there are still restrictions on the kinds of medical devices that can be manufactured using this technology. Some gadgets might need components or design elements that 3D printing does not yet support.

Competitive Landscape

Key Players

Materialise Japan (JP)
Roland dg (JP)
Siemens Healthineers
Renishaw
GE Healthcare
Stryker

Notable Recent Deals

2022: CMIC Holdings, a Tokyo-based manufacturer of medical devices, declared in May 2022 that it had reached an agreement with Israeli firm XJet to produce ceramic medical implants in Japan using XJet's 3D printing technology. The collaboration seeks to deliver superior, patient-specific implants that are more robust and resistant to deterioration.

Healthcare Policies and Regulatory Landscape

The Pharmaceutical and Medical Devices Agency (PMDA) and the Ministry of Health, Employment, and Welfare are in charge of Japan's 3D printing regulations (MHLW). The Pharmaceutical Affairs Act and the Medical Device Act regulate the 3D printing medicinal devices in Japan. Any medical device created using 3D printing and meant for use or sale in Japan must pass stringent safety and efficacy tests as part of the regulatory approval process. The MHLW is in charge of directing the regulation and implementation of medical device manufacturing standards, while the PMDA is in charge of assessing applications for approval of medical devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

3D Printing Medical Devices Market Segmentation

By Component (Revenue, USD Billion):

The 3D Printing Medical Devices market is divided into equipment, materials, and software & services depending on the component. In 2020, the market for 3D printed medical devices was dominated by software and services. During the forecast period, the cost-effectiveness, utility, uniformity, and accuracy provided by services for medical device 3D printing are anticipated to drive the segment's expansion.

Equipment
- 3D Printers
- 3D Bioprinters
Materials
Plastics
- Thermoplastics
- Photopolymers
Metals and Metal Alloys
Biomaterials
Ceramics
Paper
Wax
Other Materials
Services & Software

By Application (Revenue, USD Billion):

The market for 3D-printed medical devices is divided into wearable/implantable medical devices, other medical devices, standard prosthetics and implants, custom prosthetics and implants, tissue-engineered goods, surgical guides, and surgical tools based on the application. In 2020, the custom prosthetics and implants market sector held a greater market share. Biological materials (such skin and bones), plastics, ceramics, and metals are just a few of the materials that may be used to create highly customizable prosthetics and implants using 3D printing. The development of this market sector is anticipated to be fueled by 3D printing of custom implants, which is drawing in new investors and medical device businesses.

Surgical Guides
- Dental Guides
- Craniomaxillofacial Guides
- Orthopedic Guides
- Spinal Guides
Surgical Instruments
Surgical Fasteners
Scalpels
Retractors
Standard Prosthetics & Implants
Orthopedic Implants
Dental Prosthetics & Implants
Craniomaxillofacial Implants
Bone & Cartilage Scaffolds
Ligament & Tendon Scaffolds
Custom Prosthetics & Implants
Tissue-engineered Products
Hearing Aids
Wearable Medical Devices
Other Applications

By Technology (Revenue, USD Billion):

The market for 3D printing medical devices has been divided into various technological categories, including electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and others. The segment of these that accounted for the biggest market share in 2020 was laser beam melting (LBM). The significant market share of this sector is linked to the technology's expanding use in the dentistry sector and in the production of implants for minimally invasive surgery.

Laser Beam Melting
- Direct Metal Laser Sintering
- Selective Laser Sintering
- Selective Laser Melting
- LaserCUSING
Photopolymerization
Digital Light Processing
Stereolithography
Two-photon Polymerization
PolyJet 3D Printing
Fused Deposition Modeling
Multiphase Jet Solidification
Low-temperature Deposition Manufacturing
Microextrusion Bioprinting
Droplet Deposition/Extrusion-based Technologies
Electron Beam Melting
Three-dimensional Printing/Adhesion Bonding/Binder Jetting
Other Technologies

By End User (Revenue, USD Billion):

Hospitals and surgical centers, dentistry and orthopaedic clinics, academic institutions & research laboratories, pharma-biotech & medical device firms, and clinical research organizations make up the different end-user segments of the 3D printing medical devices market. The sector of hospitals and surgical centers held the biggest market share in 2020. The significant market share of this sector can be due to the increased uptake of cutting-edge medical technology by hospitals, the expansion of existing 3D printing facilities, and the rising affordability of 3D printing services.

Hospitals & Surgical Centers
Dental & Orthopedic Clinics
Academic Institutions & Research Laboratories
Pharma-Biotech & Medical Device Companies
Clinical Research Organizations

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.